Proposals that impact Medicare Part D and ongoing implementation of payment and regulatory issues for the Medicare Advantage program.
Issues impacting insurance coverage, prescription drugs and the federal COVID response in the American Rescue Plan Act of 2021 (PL 117-2).
Duration: February 26, 2013
to
March 31, 2021
General Issues: Medicare/Medicaid , Health Issues , Taxation/Internal Revenue Code , Pharmacy , Homeland Security , Labor Issues/Antitrust/Workplace
Spending: about $2,620,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2013: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), White House Office, Labor - Dept of (DOL), Centers For Medicare and Medicaid Services (CMS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Andrew McKechnie Health Policy Advisor, Sen. Finance Committee
Legislative Assistant, Senator Norm Coleman
Legislative Assistant, Rep. Jim Ramstad
Bipartisan Medical Technology Caucus
Sheila Murphy Legislative Director, Rep. Richard Durbin
Legislative Director, Senator Bob Kerrey
Legislative Director, Senator Ben Nelson
Legislative Director, Senator Tom Carper
LD and Interim COS, Senator Amy Klobuchar
Subcomm. on Fed. Financial Mgmnt
Senior Foreign Policy Advisor, Senator Daschle
Janet Mullins Grissom Assist. Sec., Leg. Affairs, State Department
Chief of Staff, Senator Mitch McConnell
Chief of Staff, Senator Bob Packwood
Assist. to the President, Political Affairs
John Michael Gonzalez Chief of Staff, Rep. Chris Bell
Chief of Staff, Rep. Melissa Bean
Bryant Hall Legislative Correspondent, Senator Bob Graham
Legislative Assistant, Senator Bob Graham
Health Care Counsel, Senator Bob Graham
Legislative Director, Senator Bob Graham
Staff Director, Senate Comm. on Veterans Affairs
Jay Heimbach Special Asst to the President, The White House/CoS Senator Sherrod Brown/FCC - CSB and Congressional Affairs/OLA, The White House
Lindsey Ledwin EA and Senior Scheduler, Sen. Olympia Snowe
Clerk, Sen. Comm. on Small Bus. and Entrprnrship
Staff Assist., Sen. Cohen, Special Comm. on Aging
Executive Assistant, Senator Susan Collins
Prof. Staff, Permanent Subcomm. on Investigations
Ashli Palmer Director of Floor Operations, Majority Whip James E. Clyburn; Policy Director, Assistant Democratic Leader James E. Clyburn; Chief of Staff, Rural Business Services Agency (USDA)
John Twomey Chief of Staff, HHS Office of the Asst. Sec. for Legislation (2019-2021); Policy Adviser, HHS (2017-2019); Special Asst., Office of the Secretary, HHS (2017); Staff Assistant, Rep. Tom Price (2015-2017); Intern, Rep. Doug Collins (2015)
Jeff Shapiro n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2021
Tiber Creek terminated an engagement in which they represented Cigna Corporation on April 18, 2021.
Original Filing: 301255670.xml
Lobbying Issues
Proposals that impact Medicare Part D and ongoing implementation of payment and regulatory issues for the Medicare Advantage program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues impacting insurance coverage, prescription drugs and the federal COVID response in the American Rescue Plan Act of 2021 (PL 117-2).
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on Jan. 19, 2021.
Original Filing: 301236543.xml
Lobbying Issues
Proposals that impact Medicare Part D. Ongoing implementation of payment and regulatory issues for the Medicare Advantage program. Issues related to H.R. 7839 Continuing Access to In Home IVIG Act. H.R. 7659/S. 4840, Ensuring Parity in MA for Audio-Only Telehealth Act of 2020, to amend title XVIII of the Social Security Act to require the inclusion of certain audio-only diagnoses in the determination of risk adjustment for Medicare Advantage plans, and for other purposes. Issues related to H.R. 133 / PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to P.L. 111-148, the Patient Protection and Affordable Care Act and P.L. 111-152, the Health Care and Education Reconciliation Act. Issues related to prescription drug pricing. Federal COVID response. Issues related to S. 1895, the Lower Health Care Costs Act, including: surprise billing, and transparency and information sharing in the individual and commercial markets. Issues related to H.R. 133 / PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on Oct. 20, 2020.
Original Filing: 301221060.xml
Lobbying Issues
Proposals that impact Medicare Part D. Ongoing implementation of payment and regulatory issues for the Medicare Advantage program. Issues related to H.R. 7839 Continuing Access to In Home IVIG Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to P.L. 111-148, the Patient Protection and Affordable Care Act and P.L. 111-152, the Health Care and Education Reconciliation Act. Issues related to prescription drug pricing. Federal COVID response.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on July 20, 2020.
Original Filing: 301200559.xml
Lobbying Issues
Proposals that impact Medicare Part D. Ongoing implementation of payment and regulatory issues for the Medicare Advantage program. H.R. 6800 Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to P.L. 111-148, the Patient Protection and Affordable Care Act and P.L. 111-152, the Health Care and Education Reconciliation Act, including exchanges, market reforms and coverage expansion proposals. Issues related to prescription drug pricing. Federal COVID response, including Families First Coronavirus Response Act (Public Law No. 116-127), Coronavirus Aid, Relief, and Economic Security (CARES) Act (Public Law 116-136), Paycheck Protection Program and Health Care Enhancement Act (Public Law No. 116-139), and H.R. 6800 Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on April 20, 2020.
Original Filing: 301179007.xml
Lobbying Issues
Proposals that impact Medicare Part D. Ongoing implementation of payment and regulatory issues for the Medicare Advantage program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to P.L. 111-148, the Patient Protection and Affordable Care Act and P.L. 111-152, the Health Care and Education Reconciliation Act, including exchanges, market reforms and coverage expansion proposals. Issues related to prescription drug pricing. Federal COVID response, including Coronavirus Aid, Relief, and Economic Security (CARES) Act (Public Law 116-136)
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on Jan. 21, 2020.
Original Filing: 301128373.xml
Lobbying Issues
Proposals that impact Medicare Part D. Ongoing implementation of payment and regulatory issues for the Medicare Advantage program. Issues related to the drug pricing RFI, the Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to P.L. 111-148, the Patient Protection and Affordable Care Act and P.L. 111-152, the Health Care and Education Reconciliation Act, including exchanges, cost sharing reduction, market reforms and coverage expansion proposals, and non-discrimination provisions. Issues related to prescription drug pricing. Issues related to S. 1895, the Lower Health Care Costs Act and S. 2543, The Prescription Drug Pricing Reduction Act of 2019, and HR 3 the Elijah E. Cummings Lower Drug Costs Now Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 748/S. 684, Middle Class Health Benefits Tax Repeal Act of 2019, legislation to repeal a 40% ACA excise tax on certain employer-sponsored health insurance plans. S.172/H.R. 1398, the Health Insurance Tax (HIT) Relief Act of 2019, legislation to suspend the ACA's health insurance tax (HIT) in 2020 and 2021. S.80, Jobs and Premium Protection Act, full repeal of the HIT. Issues related to P.L. 111-148, the Patient Protection and Affordable Care Act and P.L. 111-152, the Health Care and Education Reconciliation Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2019
In Q3, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on Oct. 21, 2019.
Original Filing: 301078181.xml
Lobbying Issues
Issues related to payment and policy issues for Medicare Advantage and Medicare Part D, including transparency requirements and benefit design issues. Issues related to the Prescription Drug Pricing Reduction Act of 2019, and H.R. 2113, The Prescription Drug Sunshine Transparency Accountability and Reporting Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to P.L. 111-148, the Patient Protection and Affordable Care Act and P.L. 111-152, the Health Care and Education Reconciliation Act. Issues related to the Lower Health Care Costs Act, S.1895, including surprise billing and transparency requirements. Issues related to - June 24, 2019 Executive Order, Improving Price and Quality Transparency in American Healthcare to Put Patients First, and 42 C.F.R. Part 2, and H.R. 2062 The Overdose Prevention and Patient Safety Act, and S. 1012 The Protecting Jessica Grubbs Legacy Act.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on July 22, 2019.
Original Filing: 301056641.xml
Lobbying Issues
Issues related to payment and policy issues for Medicare Advantage and Medicare Part D, including transparency requirements and benefit design issues.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to P.L. 111-148, the Patient Protection and Affordable Care Act and P.L. 111-152, the Health Care and Education Reconciliation Act. Issues related to the Lower Health Care Costs Act, S.1895, including surprise billing and transparency requirements
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on April 22, 2019.
Original Filing: 301035710.xml
Lobbying Issues
Ongoing implementation of payment and regulatory issues for the Medicare Advantage program. CMS-4182-P/CMS-4182-CN: Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs for Contract Year 2019.
Issues related to the drug pricing RFI, the Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.
Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs for Contract Year 2020 (CMS-4185-P).
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 748/S. 684, Middle Class Health Benefits Tax Repeal Act of 2019, legislation to repeal a 40% ACA excise tax on certain employer-sponsored health insurance plans.
S.172/H.R. 1398, the Health Insurance Tax (HIT) Relief Act of 2019, legislation to suspend the ACA's health insurance tax (HIT) in 2020 and 2021. S.80, Jobs and Premium Protection Act, full repeal of the HIT.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues relating to P.L. 111-148, the Patient Protection and Affordable Care Act and P.L. 111-152, the Health Care and Education Reconciliation Act, including exchanges, cost sharing reduction, market reforms and coverage expansion proposals, and non-discrimination provisions.
Issues related to H.R. 861, the End Surprise Billing Act.
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on Jan. 18, 2019.
Original Filing: 301009390.xml
Lobbying Issues
Ongoing implementation of payment and regulatory issues for the Medicare Advantage program. Issues related to the opioid epidemic, including H.R. 6, SUPPORT for Patients and Communities Act and S. 2680, the Opioid Crisis Response Act of 2018. Issues related to the drug pricing RFI, the Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
The high cost employer health insurance excise tax, including H.R. 173 and S. 58, the Middle Class Health Benefits Tax Repeal Act of 2017, and H.R. 4616, the Employer Relief Act of 2018, regarding a one-year delay of the Cadillac Tax. H.R. 4620, the Protecting Families and
Small Businesses Act of 2017, regarding relief from the Health Insurance Tax.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to the drug pricing RFI, the Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. Issues related to the proposed rule: Removal Of Safe Harbor Protection for Rebates to Plans or PBMs Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on Oct. 22, 2018.
Original Filing: 300995074.xml
Lobbying Issues
Ongoing implementation of payment and regulatory issues for the Medicare Advantage program. Issues related to the opioid epidemic and H.R. 6, SUPPORT for Patients and Communities Act. Issues related to the drug pricing RFI, the Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. Issues related to implementation of provisions in the Bipartisan Budget Act of 2018 that require increased integration of Medicare and Medicaid benefits by Dual Eligible Special Needs Plans beginning in 2021.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to P.L. 111-148, the Patient Protection and Affordable Care Act and P.L. 111-152, the Health Care and Education Reconciliation Act, , including exchanges, cost sharing reduction, market reforms, and non-discrimination provisions. The high cost employer health insurance excise tax, including H.R. 173 and S. 58, the Middle Class Health Benefits Tax Repeal Act of 2017, and H.R. 4616, the Employer Relief Act of 2018, regarding a one-year delay of the Cadillac Tax. H.R. 4620, the Protecting Families and Small Businesses Act of 2017, regarding relief from the Health Insurance Tax. Substance use disorders and 42 CFR Part 2 - Confidentiality of Substance Use Disorder Patient Records, specifically H.R. 3545, H.R. 5795, and H.R.6082, the Overdose Prevention and Patient Safety Act (OPPS Act) and H.R. 6, the SUPPORT for Patients and Communities Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to P.L. 111-148, the Patient Protection and Affordable Care Act and P.L. 111-152, and the Health Care and Education Reconciliation Act. The high cost employer health insurance excise tax, including H.R. 173 and S. 58, the Middle Class Health Benefits Tax Repeal Act of 2017. H.R.5963, To delay the reimposition of the annual fee on health insurance providers until after 2020, regarding relief from the Health Insurance Tax.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2018
In Q2, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on July 20, 2018.
Original Filing: 300976839.xml
Lobbying Issues
Ongoing implementation of payment and regulatory issues for the Medicare Advantage program. Issues related to the opioid epidemic and H.R. 6, SUPPORT for Patients and Communities Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to P.L. 111-148, the Patient Protection and Affordable Care Act and P.L. 111-152, and the Health Care and Education Reconciliation Act. The high cost employer health insurance excise tax. Substance use disorders and 42 CFR Part 2 - Confidentiality of Substance Use Disorder Patient Records, specifically H.R. 3545, H.R. 5795, and H.R.6082, the Overdose Prevention and Patient Safety Act (OPPS Act). H.R. 173/S. 53 the Middle Class Health Benefits Tax Repeal Act of 2017.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to P.L. 111-148, the Patient Protection and Affordable Care Act and P.L. 111-152, and the Health Care and Education Reconciliation Act. Issues related to the implementation of international tax provisions under P.L. 115-97, the Tax Cuts and Jobs Act. H.R. 173/S. 53 the Middle Class Health Benefits Tax Repeal Act of 2017.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2018
In Q1, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on April 20, 2018.
Original Filing: 300954785.xml
Lobbying Issues
Ongoing implementation of payment and regulatory issues for the Medicare Advantage program; CMS-4182-p/CMS-4182-CN: Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription drug Benefit Programs for Contract Year 2019.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to PL 111-148, the Patient Protection and Affordable Care Act and PL 111-152, the Health Care and Education Reconciliation Act, and HR 1628, the American Health Act of 2017, the Better Care Reconciliation Act, including exchanges, cost sharing reduction, market reforms, and non-discrimination provisions. The high cost employer health insurance excise tax, including HR 173 and S 58, the Middle Class Health Benefits Tax Repeal Act of 2017, and HR 4616, regarding a one year delay of the Cadillac Tax. HR 4620, regarding relief from the Health Insurance Tax. Substance use disorders and 42 CFR Part 2 - Confidentiality of Substance Use Disorder Patient Records, specifically the Overdose Prevention and Patient Safety Act (OPPS Act),. Issues related to HR 1625, The Consolidated Appropriations Act of 2018.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to P.L. 111-148, the Patient Protection and Affordable Care Act and P.L. 111-152, the Health Care and Education Reconciliation Act, and H.R. 1628, the American Health Care Act of 2017, the Better Care Reconciliation Act. the high cost employer health insurance excise tax, including HR 173 and S 58, the Middle Class Health Benefits Tax Repeal Act of 2017 and HR 4616, regarding a one-year delay of the Cadillac Tax. HR 4620, regarding relief from the Health Insurance Tax. Senate motion to concur in the House amendment to the Senate amendment to H.R.195, CR/CHIP, with further amendment (includes: CR funding until February 8, 2018; 6 year CHIP; ACA tax delays).
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2017
In Q4, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on Jan. 22, 2018.
Original Filing: 300934074.xml
Lobbying Issues
Ongoing implementation of payment and regulatory issues for the Medicare Advantage program
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to P.L. 111-148, the Patient Protection and Affordable Care Act and P.L. 111-152, the Health Care and Education Reconciliation Act, and H.R. 1628, the American Health Care Act of 2017, the Better Care Reconciliation Act, including exchanges, cost sharing reduction, market reforms, and non-discrimination provisions. The high cost employer health insurance excise tax, including H.R. 173 and S. 58, the Middle Class Health Benefits Tax Repeal Act of 2017, and H.R. 4616, regarding a one-year delay of the Cadillac Tax. H.R. 4620, regarding relief from the Health Insurance Tax. Issues relating to P.L. 114-10, the Medicare Access and CHIP Reauthorization Act, including alternative payment models. Substance use disorders and 42 CFR Part 2 - Confidentiality of Substance Use Disorder Patient Records, specifically the Overdose Prevention and Patient Safety Act (OPPS Act), H.R. 3545 and Protecting Jessica Grubbs Legacy Act (Legacy Act), S. 1850
Agencies Lobbied
U.S. Senate
Lobbying Issues
Tax Cuts and Jobs Act (H.R. 1) Public Law 115-97. Issues related to P.L. 111-148, the Patient Protection and Affordable Care Act and P.L. 111-152, the Health Care and Education Reconciliation Act, and H.R. 1628, the American Health Care Act of 2017, and the Better Care Reconciliation Act. The high cost employer health insurance excise tax, including H.R. 173 and S. 58, the Middle Class Health Benefits Tax Repeal Act of 2017, and H.R. 4616, regarding a one-year delay of the Cadillac Tax. H.R. 4620, regarding relief from the Health Insurance Tax.
H. Con. Res. 71, the FY2018 Budget Resolution and issues related to corporate tax reform.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Improving Cybersecurity in the Health Care Industry
Agencies Lobbied
Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues related to regulations on claims procedure for plans providing disability benefits.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
3rd Quarter, 2017
In Q3, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on Oct. 20, 2017.
Original Filing: 300911869.xml
Lobbying Issues
Issues related to funding for Medicare Advantage
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to implementation of PPACA (PL: 111-148) and its impact on health insurance; Issues related to the American Health Care Act and Better Care Reconciliation Act (HR 1628) and legislation proposed by Senators Graham and Cassidy and their impact on health insurance. Substance use disorders and 42 CFR Part 2 - Confidentiality of Substance Use Disorder Patient Records.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the American Health Care Act and Better Care Reconciliation Act (HR 1628) and legislation proposed by Senators Graham and Cassidy and their impact on health insurance and the taxation of health plans and employer sponsored health coverage. H. Con. Res. 71, the FY2018 Budget Resolution and issues related to corporate tax reform
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Improving Cybersecurity in the Health Care Industry
Agencies Lobbied
Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues related to the regulation of disability insurance.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
2nd Quarter, 2017
In Q2, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on July 20, 2017.
Original Filing: 300892396.xml
Lobbying Issues
Issues related to funding for Medicare Advantage and the implementation of the quality bonus program
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to implementation of PPACA (PL: 111-148) and its impact on health insurance; Issues related to the American Health Care Act and Better Care Reconciliation Act (HR 1628) and their impact on health insurance. Issues related to the regulation of disability insurance
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the American Health Care Act and Better Care Reconciliation Act (HR 1628) and their impact on health insurance and the taxation of health plans and employer sponsored health coverage. Issues related to the regulation of disability insurance
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Improving Cybersecurity in the Health Care Industry
Agencies Lobbied
Health & Human Services - Dept of (HHS)
1st Quarter, 2017
In Q1, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on April 20, 2017.
Original Filing: 300873160.xml
Lobbying Issues
Issues related to funding for Medicare Advantage and the implementation of the quality bonus program
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to implementation of PPACA (PL: 111-148) and its impact on health insurance; Issues related to the American Health Care Act (HR 1628) and its impact on health insurance
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the American Health Care Act (HR 1628) and its impact on health insurance and the taxation of health plans and employer sponsored health coverage
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2016
In Q4, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on Jan. 23, 2017.
Original Filing: 300854883.xml
Lobbying Issues
Ongoing implementation of issues for the Medicare Advantage and Medicare Part D prescription drug programs. Issues relating to general health and health care legislation. Issues related to the corporate taxation of health benefits and providers of health coverage. Implementation of Public Law no: 111-148, the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Medicare/Medicaid
Lobbying Issues
Issues related to the corporate taxation of health benefits and providers of health coverage.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2016
In Q3, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on Oct. 20, 2016.
Original Filing: 300835163.xml
Lobbying Issues
Ongoing implementation of issues for the Medicare Advantage and Medicare Part D prescription drug programs. Issues relating to general health and health care legislation. Issues related to the corporate taxation of health benefits and providers of health coverage. Implementation of Public Law no: 111-148, the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Medicare/Medicaid
Lobbying Issues
Issues related to the corporate taxation of health benefits and providers of health coverage.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2016
In Q2, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on July 20, 2016.
Original Filing: 300818313.xml
Lobbying Issues
Ongoing implementation of issues for the Medicare Advantage and Medicare Part D prescription drug programs. Issues relating to general health and health care legislation. Issues related to the corporate taxation of health benefits and providers of health coverage. Implementation of Public Law no: 111-148, the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Medicare/Medicaid
Lobbying Issues
Issues related to the corporate taxation of health benefits and providers of health coverage.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
HR 1704 Personal Data Notification and Protection Act of 2015. HR 555 Federal Exchange Data Breach Notification Act of 2015. S.177 Data Security and Breach Notification Act of 2015. S.1027 Data Breach Notification and Punishing Cyber Criminals Act of 2015. H.R.1770 Data Security and Breach Notification Act of 2015. H.R.2205 Data Security Act of 2015. S.961 Data Security Act of 2015. S.1158 Consumer Privacy Protection Act of 2015. H.R. 4651/S. 2604, Digital Security Commission Act.
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
In Q1, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on April 20, 2016.
Original Filing: 300802297.xml
Lobbying Issues
Ongoing implementation of issues for the Medicare Advantage and Medicare Part D prescription drug programs. Issues relating to general health and health care legislation. Issues related to the corporate taxation of health benefits and providers of health coverage. Implementation of Public Law no: 111-148, the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Medicare/Medicaid
Lobbying Issues
Issues related to the corporate taxation of health benefits and providers of health coverage.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
HR 1704 Personal Data Notification and Protection Act of 2015. HR 555 Federal Exchange Data Breach Notification Act of 2015. S.177 Data Security and Breach Notification Act of 2015. S.1027 Data Breach Notification and Punishing Cyber Criminals Act of 2015. H.R.1770 Data Security and Breach Notification Act of 2015. H.R.2205 Data Security Act of 2015. S.961 Data Security Act of 2015. S.1158 Consumer Privacy Protection Act of 2015.
Agencies Lobbied
U.S. Senate
4th Quarter, 2015
In Q4, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on Jan. 20, 2016.
Original Filing: 300779499.xml
Lobbying Issues
Ongoing implementation of issues for the Medicare Advantage and Medicare Part D prescription drug programs. Issues relating to general health and health care legislation. Issues related to the corporate taxation of health benefits and providers of health coverage. Implementation of Public Law no: 111-148, the Patient Protection and Affordable Care Act. H.R. 2029, Consolidated Appropriations Act of 2016. S. 1946, Tax Relief Extension Act of 2015.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Ongoing implementation of issues for the Medicare Advantage and Medicare Part D prescription drug programs. Issues relating to general health and health care legislation. Issues related to the corporate taxation of health benefits and providers of health coverage. Implementation of Public Law no: 111-148, the Patient Protection and Affordable Care Act. S.1099, PACE Act. S.2045, Middle Class Health Benefits Tax Repeal Act of 2015. H.R. 2029, Consolidated Appropriations Act of 2016. S. 1946, Tax Relief Extension Act of 2015.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the corporate taxation of health benefits and providers of health coverage. S.2045, Middle Class Health Benefits Tax Repeal Act of 2015. H.R. 2029, Consolidated Appropriations Act of 2016. S. 1946, Tax Relief Extension Act of 2015.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
HR 1704 Personal Data Notification and Protection Act of 2015. HR 555 Federal Exchange Data Breach Notification Act of 2015. S.177 Data Security and Breach Notification Act of 2015. S.1027 Data Breach Notification and Punishing Cyber Criminals Act of 2015. H.R.1770 Data Security and Breach Notification Act of 2015. H.R.2205 Data Security Act of 2015. S.961 Data Security Act of 2015. S.1158 Consumer Privacy Protection Act of 2015.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to antitrust review of the proposed Anthem-Cigna transaction.
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
3rd Quarter, 2015
In Q3, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on Oct. 20, 2015.
Original Filing: 300762202.xml
Lobbying Issues
Ongoing implementation of issues for the Medicare Advantage and Medicare Part D prescription drug programs. Issues relating to general health and health care legislation. Issues related to the corporate taxation of health benefits and providers of health coverage. Implementation of Public Law no: 111-148, the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Ongoing implementation of issues for the Medicare Advantage and Medicare Part D prescription drug programs. Issues relating to general health and health care legislation. Issues related to the corporate taxation of health benefits and providers of health coverage. Implementation of Public Law no: 111-148, the Patient Protection and Affordable Care Act. S.1099, PACE Act. S.2045, Middle Class Health Benefits Tax Repeal Act of 2015.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the corporate taxation of health benefits and providers of health coverage. S.2045, Middle Class Health Benefits Tax Repeal Act of 2015.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
HR 1704 Personal Data Notification and Protection Act of 2015. HR 555 Federal Exchange Data Breach Notification Act of 2015. S.177 Data Security and Breach Notification Act of 2015. S.1027 Data Breach Notification and Punishing Cyber Criminals Act of 2015. H.R.1770 Data Security and Breach Notification Act of 2015. H.R.2205 Data Security Act of 2015. S.961 Data Security Act of 2015. S.1158 Consumer Privacy Protection Act of 2015.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to antitrust review of the proposed Anthem-Cigna transaction.
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
2nd Quarter, 2015
In Q2, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on July 20, 2015.
Original Filing: 300745906.xml
Lobbying Issues
Ongoing implementation of issues for the Medicare Advantage and Medicare Part D prescription drug programs. Issues relating to general health and health care legislation. Issues related to the corporate taxation of health benefits and providers of health coverage. Implementation of Public Law no: 111-148, the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Ongoing implementation of issues for the Medicare Advantage and Medicare Part D prescription drug programs. Issues relating to general health and health care legislation. Issues related to the corporate taxation of health benefits and providers of health coverage. Implementation of Public Law no: 111-148, the Patient Protection and Affordable Care Act. H.R. 83, Consolidated and Further Continuing Appropriations Act, 2015, and the treatment of expatriate health plans under the ACA.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the corporate taxation of health benefits and providers of health coverage.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
S.1027, Data Breach Notification and Punishing Cyber Criminals Act of 2015. H.R.1770, Data Security and Breach Notification Act of 2015. S.177 Data Security and Breach Notification Act of 2015. H.R.1704, Personal Data Notification and Protection Act of 2015. H.R.2205, Data Security Act of 2015. S.961, Data Security Act of 2015. S.1158, Consumer Privacy Protection Act of 2015. Other general data breach issues. S. 1376, The National Defense Authorization Act of 2016 (NDAA).
Agencies Lobbied
U.S. Senate
1st Quarter, 2015
In Q1, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on April 20, 2015.
Original Filing: 300727261.xml
Lobbying Issues
Ongoing implementation of issues for the Medicare Advantage and Medicare Part D prescription drug programs. Issues relating to general health and health care legislation. Issues related to the corporate taxation of health benefits and providers of health coverage. Implementation of Public Law no: 111-148, the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Ongoing implementation of issues for the Medicare Advantage and Medicare Part D prescription drug programs. Issues relating to general health and health care legislation. Issues related to the corporate taxation of health benefits and providers of health coverage. Implementation of Public Law no: 111-148, the Patient Protection and Affordable Care Act. H.R. 83, Consolidated and Further Continuing Appropriations Act, 2015, and the treatment of expatriate health plans under the ACA.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the corporate taxation of health benefits and providers of health coverage.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2014
In Q4, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on Jan. 20, 2015.
Original Filing: 300706442.xml
Lobbying Issues
Ongoing implementation of issues for the Medicare Advantage and Medicare Part D prescription drug programs. Implementation of various CMS demonstration programs. Issues relating to general health and health care legislation. Issues related to the corporate taxation of health benefits and providers of health coverage. Implementation of Public Law No: 111-148 the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Ongoing implementation of issues for the Medicare Advantage and Medicare Part D prescription drug programs. Implementation of various CMS demonstration programs. Issues relating to general health and health care legislation. Issues related to the corporate taxation of health benefits and providers of health coverage. Implementation of Public Law No: 111-148 the Patient Protection and Affordable Care Act. H.R. 83, Consolidated and Further Continuing Appropriations Act, 2015, and the treatment of expatriate health plans under the ACA.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to the corporate taxation of health benefits and providers of health coverage.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2014
In Q3, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on Oct. 20, 2014.
Original Filing: 300687408.xml
Lobbying Issues
Ongoing implementation of issues for the Medicare Advantage and Medicare Part D prescription drug programs. Implementation of various CMS demonstration programs. Issues relating to general health and health care legislation. Issues related to the corporate taxation of health benefits and providers of health coverage. Implementation of Public Law No: 111-148 the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare/Medicaid
Lobbying Issues
Issues related to the corporate taxation of health benefits and providers of health coverage.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2014
In Q2, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on July 21, 2014.
Original Filing: 300668557.xml
Lobbying Issues
Ongoing implementation of issues for the Medicare Advantage and Medicare Part D prescription drug programs. Implementation of various CMS demonstration programs. Issues relating to general health and health care legislation. Issues related to the corporate taxation of health benefits and providers of health coverage. Implementation of Public Law No: 111-148 the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare/Medicaid
Lobbying Issues
Issues related to the corporate taxation of health benefits and providers of health coverage.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2014
In Q1, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on April 21, 2014.
Original Filing: 300646250.xml
Lobbying Issues
Ongoing implementation of issues for the Medicare Advantage and Medicare Part D prescription drug programs. Implementation of various CMS demonstration programs. Issues relating to general health and health care legislation. Issues related to the corporate taxation of health benefits and providers of health coverage. Implementation of Public Law No: 111-148 the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare/Medicaid
Lobbying Issues
Issues related to the corporate taxation of health benefits and providers of health coverage.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2013
In Q4, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on Jan. 21, 2014.
Original Filing: 300622587.xml
Lobbying Issues
Ongoing implementation of issues for the Medicare Advantage and Medicare Part D prescription drug programs. Implementation of various CMS demonstration programs. Issues relating to general health and health care legislation. Issues related to the corporate taxation of health benefits and providers of health coverage. Implementation of Public Law No: 111-148 the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare/Medicaid
Lobbying Issues
Issues related to the corporate taxation of health benefits and providers of health coverage.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2013
In Q3, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on Oct. 21, 2013.
Original Filing: 300605870.xml
Lobbying Issues
Ongoing implementation of issues for the Medicare Advantage and Medicare Part D prescription drug programs. Implementation of various CMS demonstration programs. Issues relating to general health and health care legislation. Issues related to the corporate taxation of health benefits and providers of health coverage. Implementation of Public Law No: 111-148 the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare/Medicaid
Lobbying Issues
Issues related to the corporate taxation of health benefits and providers of health coverage.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2013
In Q2, Tiber Creek lobbied for Cigna Corporation , earning $80,000. The report was filed on July 22, 2013.
Original Filing: 300585093.xml
Lobbying Issues
Ongoing implementation of issues for the Medicare Advantage and Medicare Part D prescription drug programs. Implementation of various CMS demonstration programs. Issues relating to general health and health care legislation. Issues related to the corporate taxation of health benefits and providers of health coverage. Implementation of Public Law No: 111-148 the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare/Medicaid
Lobbying Issues
Issues related to the corporate taxation of health benefits and providers of health coverage.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2013
In Q1, Tiber Creek lobbied for Cigna Corporation , earning $60,000. The report was filed on April 22, 2013.
Original Filing: 300563715.xml
Lobbying Issues
Ongoing implementation of issues for the Medicare Advantage and Medicare Part D prescription drug programs. Implementation of various CMS demonstration programs. Issues relating to general health and health care legislation. Issues related to the corporate taxation of health benefits and providers of health coverage.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare/Medicaid
Lobbying Issues
Issues related to the corporate taxation of health benefits and providers of health coverage.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2013
Tiber Creek filed a lobbying registration on April 8, 2013 to represent Cigna Corporation, effective Feb. 26, 2013.
Original Filing: 300548038.xml
Issue(s) they said they’d lobby about: Ongoing implementation of issues for the Medicare Advantage and Medicare Part D prescription drug programs. Implementation of various CMS demonstration programs. Issues relating to general health and health care legislation. Issues related to the corporate taxation of health benefits and providers of health coverage. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...